Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

803 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Crohn's disease: beyond antagonists of tumour necrosis factor.
Peyrin-Biroulet L, Desreumaux P, Sandborn WJ, Colombel JF. Peyrin-Biroulet L, et al. Among authors: sandborn wj. Lancet. 2008 Jul 5;372(9632):67-81. doi: 10.1016/S0140-6736(08)60995-2. Lancet. 2008. PMID: 18603161 Review.
A controlled trial of anti-tumor necrosis factor alpha antibody for Crohn's disease.
Sandborn WJ. Sandborn WJ. Gastroenterology. 1997 Sep;113(3):1042-3. doi: 10.1016/s0016-5085(97)70205-1. Gastroenterology. 1997. PMID: 9288004 Clinical Trial. No abstract available.
Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.
Sandborn WJ, Hanauer SB. Sandborn WJ, et al. Inflamm Bowel Dis. 1999 May;5(2):119-33. doi: 10.1097/00054725-199905000-00008. Inflamm Bowel Dis. 1999. PMID: 10338381 Review.
Mycophenolate mofetil for Crohn's disease?
Lowry PW, Sandborn WJ, Lipsky JJ. Lowry PW, et al. Among authors: sandborn wj. Lancet. 1999 Jul 3;354(9172):3-4. doi: 10.1016/S0140-6736(99)00152-X. Lancet. 1999. PMID: 10406354 No abstract available.
Successful management of Crohn's disease of the ileoanal pouch with infliximab.
Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Ricart E, et al. Among authors: sandborn wj. Gastroenterology. 1999 Aug;117(2):429-32. doi: 10.1053/gast.1999.0029900429. Gastroenterology. 1999. PMID: 10419926
Steroid-dependent Crohn's disease.
Sandborn WJ. Sandborn WJ. Can J Gastroenterol. 2000 Sep;14 Suppl C:17C-22C. doi: 10.1155/2000/513130. Can J Gastroenterol. 2000. PMID: 11023556 Review.
Infliximab for the treatment of orofacial Crohn's disease.
Mahadevan U, Sandborn WJ. Mahadevan U, et al. Among authors: sandborn wj. Inflamm Bowel Dis. 2001 Feb;7(1):38-42. doi: 10.1097/00054725-200102000-00006. Inflamm Bowel Dis. 2001. PMID: 11233659
Management of Crohn's disease in adults.
Hanauer SB, Sandborn W; Practice Parameters Committee of the American College of Gastroenterology. Hanauer SB, et al. Am J Gastroenterol. 2001 Mar;96(3):635-43. doi: 10.1111/j.1572-0241.2001.3671_c.x. Am J Gastroenterol. 2001. PMID: 11280528 Review. No abstract available.
Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients.
Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Ricart E, et al. Among authors: sandborn wj. Am J Gastroenterol. 2001 Mar;96(3):722-9. doi: 10.1111/j.1572-0241.2001.03612.x. Am J Gastroenterol. 2001. PMID: 11280541
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial.
Sandborn WJ, Feagan BG, Hanauer SB, Present DH, Sutherland LR, Kamm MA, Wolf DC, Baker JP, Hawkey C, Archambault A, Bernstein CN, Novak C, Heath PK, Targan SR; CDP571 Crohn's Disease Study Group. Sandborn WJ, et al. Gastroenterology. 2001 May;120(6):1330-8. doi: 10.1053/gast.2001.24042. Gastroenterology. 2001. PMID: 11313302 Clinical Trial.
803 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback